RT @kalavisvanathan: Excited to highlight study @PriteshSKaria and team conducted while a doc student@JohnsHopkinsEPI @JohnsHopkinsSPH @ho…
Excited to highlight study @PriteshSKaria and team conducted while a doc student@JohnsHopkinsEPI @JohnsHopkinsSPH @hopkinskimmel Outlines impt nationwide differences in uptake of salpingectomy for ova cancer risk reduction.
RT @PriteshSKaria: Excited to share our work in @CAPR_AACR on dissemination of opportunistic salpingectomy (OS) for ovarian cancer preventi…
RT @PriteshSKaria: Excited to share our work in @CAPR_AACR on dissemination of opportunistic salpingectomy (OS) for ovarian cancer preventi…
Excited to share our work in @CAPR_AACR on dissemination of opportunistic salpingectomy (OS) for ovarian cancer prevention using inpatient & outpatient data. We offer the 1st complete look at OS uptake & show large differences in uptake by clinica
#OnlineFirst: Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States. https://t.co/XonV3aXeRt @JohnsHopkinsSPH @ColumbiaMSPH @kalavisvanathan @PriteshSKaria https://t.co/QTY4UX9szi
RT @OvcaPapers: Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States https://t.co/xm…
RT @OvcaPapers: Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States https://t.co/xm…
RT @OvcaPapers: Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States https://t.co/xm…
RT @OvcaPapers: Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States https://t.co/xm…
Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States https://t.co/xm1PfNobuM